Vascular Access Devices from Access Vascular
Access Vascular is offering our suite of vascular access solutions designed to help clinicians address common catheter complications that afflict patients while helping save hospitals time and money.
Our devices are built upon the foundation of our proprietary hydrophilic biomaterial featuring MIMIX™ technology, which has demonstrated a statistically significant reduction in complications in retrospective clinical data and demonstrated an average of 97% less thrombus accumulation on its surface (based on platelet count)* compared to standard polyurethane catheters.
Our first two device families, HydroPICC® and HydroMID® are commercially available in the United States
HydroPICC®
4 French single lumen PICC catheter
5 French dual lumen PICC catheter
*Bunch, J. (2022). A Retrospective Assessment of Peripheral Catheter Failures Focusing on Catheter Composition. Journal of Infusion Nursing.
**Data on file at Access Vascular. Reduction of thrombus accumulation was evaluated using in vitro and in vivo models. Pre-clinical in vitro/in vivo evaluations do not necessarily predict clinical performance with respect to thrombus formation
Are you interested in learning more about our products?
